LONG-TERM NEUROCOGNITIVE AND PSYCHOSOCIAL OUTCOMES IN PEDIATRIC ATTENTION-DEFICIT/HYPERACTIVITY DISORDER FOLLOWING SUSTAINED PHARMACOTHERAPY: A COMPREHENSIVE REVIEW OF CURRENT META-ANALYTICAL EVIDENCE
DOI:
https://doi.org/10.31435/ijitss.1(49).2026.5006Keywords:
ADHD, Pediatric Psychiatry, Pharmacotherapy, Methylphenidate, Neurodevelopment, Psychosocial Safety, Treatment AdherenceAbstract
Objectives: This review investigates the long-term neurocognitive and psychosocial outcomes of sustained pharmacotherapy in pediatric Attention-Deficit/Hyperactivity Disorder (ADHD). The primary goal is to determine whether chronic treatment facilitates neurobiological maturation and functional thriving beyond acute symptom relief.
Methods: A systematic synthesis of meta-analyses and large-scale longitudinal cohort studies from recent years was conducted. The review focused on developmental trajectories, psychosocial outcomes, and physiological effects of ADHD pharmacotherapy, drawing on evidence from both clinical trials and population-based registries.
Findings: Evidence suggests that sustained treatment acts as a catalyst for “neuro-normalization,” supporting structural maturation of the basal ganglia and enhanced white matter connectivity. Psychosocially, consistent adherence is a potent protective factor, significantly reducing the risks of criminal convictions and accidental injuries. Early intervention stabilizes developmental trajectories during critical periods. While improvements in behavioral productivity are more pronounced than gains in long-term academic performance, cumulative evidence indicates that persistent pharmacotherapy effectively buffers against major social and physical morbidities, particularly when maintained through late adolescence.
Conclusions: Long-term ADHD management provides a vital physiological foundation for development but remains a dynamic process dependent on treatment continuity. Optimal outcomes require a holistic approach that integrates medical intervention with innovative monitoring technologies and intensive family-based support to safeguard the future potential of neurodivergent youth.
References
Ayano, G., Demelash, S., Gizachew, Y., Tsegay, L., & Alati, R. (2023). The global prevalence of attention deficit hyperactivity disorder in children and adolescents: An umbrella review of meta-analyses. Journal of Affective Disorders, 339, 860–866. https://doi.org/10.1016/j.jad.2023.07.071
Humphreys, K. L., Eng, T., & Lee, S. S. (2013). Stimulant medication and substance use outcomes: A meta-analysis. JAMA Psychiatry, 70(7), 740–749. https://doi.org/10.1001/jamapsychiatry.2013.1273
Volkow, N. D., Wang, G. J., Tomasi, D., Kollins, S. H., Wigal, T. L., Newcorn, J. H., Telang, F. W., Fowler, J. S., Logan, J., Wong, C. T., & Swanson, J. M. (2012). Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. Journal of Neuroscience, 32(3), 841–849. https://doi.org/10.1523/JNEUROSCI.4461-11.2012
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012). Medication for attention deficit-hyperactivity disorder and criminality. New England Journal of Medicine, 367(21), 2006–2014. https://doi.org/10.1056/NEJMoa1203241
Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Konno, R., Rosello, M. G., Scintilla, F., Coghill, D., Panei, P., Gennaro, M., Cipriani, A., & Castellanos, F. X. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 5(9), 727–738. https://doi.org/10.1016/S2215-0366(18)30269-4
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Bonvicini, C., Asherson, P., Rohde, L. A., Buitelaar, J. K., Franke, B., Grevet, E. H., Haavik, J., Stefanatos, C., Low, A. M., Mick, E., ... Wang, Y. (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818. https://doi.org/10.1016/j.neubiorev.2021.01.022
Hoogman, M., Muetzel, R., Guimaraes, J. P., Shumskaya, E., Mennes, M., Zwiers, M. P., Jahanshad, N., Sudre, G., Wolfers, T., Earl, E. A., Soliva Vila, J. C., Vives-Gilabert, Y., Khadka, S., Novotny, S. E., Hartman, C. A., Heslenfeld, D. J., Schweren, L. J. S., Ambrosino, S., Oranje, B., ... Franke, B. (2019). Brain imaging of the cortex in ADHD: A coordinated analysis of large-scale clinical and population-based samples. American Journal of Psychiatry, 176(7), 531–542. https://doi.org/10.1176/appi.ajp.2019.18091033
Rubia, K. (2018). Cognitive neuroscience of attention deficit hyperactivity disorder (ADHD) and its clinical translation. Frontiers in Human Neuroscience, 12, Article 100. https://doi.org/10.3389/fnhum.2018.00100
Ghirardi, L., Chen, Q., Chang, Z., Kuja-Halkola, R., Skoglund, C., Quinn, P. D., D'Onofrio, B. M., & Larsson, H. (2020). Use of medication for attention-deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co-occurring neurodevelopmental disorders. Journal of Child Psychology and Psychiatry, 61(12), 1330–1339. https://doi.org/10.1111/jcpp.13136
Prasad, V., Brogan, E., Mulvaney, C., Grainge, M., Stanton, W., & Sayal, K. (2013). How effective are drug treatments for children with ADHD at improving on-task behaviour and academic achievement in the school classroom? A systematic review and meta-analysis. European Child & Adolescent Psychiatry, 22(4), 203–216. https://doi.org/10.1007/s00787-012-0346-x
Storebø, O. J., et al. (2015). Methylphenidate for children and adolescents with ADHD: A systematic review and meta-analysis of outcomes. Cochrane Database of Systematic Reviews, (11). https://doi.org/10.1002/14651858.CD009885.pub2
Swanson, J. M., Arnold, L. E., Molina, B. S. G., Sibley, M. H., Hechtman, L. T., Hinshaw, S. P., Abikoff, H. B., Stehli, A., Owens, E. B., Mitchell, J. T., Nichols, Q., Howard, A., Greenhill, L. L., Hoza, B., Newcorn, J. H., Jensen, P. S., Vitiello, B., Wigal, T., Epstein, J. N., ... MTA Cooperative Group. (2017). Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: Symptom persistence, source discrepancy, and height suppression. Journal of Child Psychology and Psychiatry, 58(6), 663–678. https://doi.org/10.1111/jcpp.12684
Zhang, L., Li, L., Du Rietz, E., et al. (2024). ADHD pharmacotherapy and long-term risk of cardiovascular diseases. JAMA Psychiatry, 81(2), 178–187. https://doi.org/10.1001/jamapsychiatry.2023.4294
Cohen, S. C., Mulqueen, J. M., Ferracioli-Oda, E., Stuckelman, Z. D., Coughlin, C. G., Leckman, J. F., & Bloch, M. H. (2015). Meta-analysis: Risk of tics associated with psychostimulant use in attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 54(9), 728–736. https://doi.org/10.1016/j.jaac.2015.06.011
Onnela, J. P., & Rauch, S. L. (2016). Harnessing smartphone-based digital phenotyping to enhance behavioral and mental health. Neuropsychopharmacology, 41(7), 1691–1696. https://doi.org/10.1038/npp.2016.7
Torous, J., Kiang, M. V., Lorme, J., & Onnela, J. P. (2016). New tools for new research in psychiatry: A scalable and customizable platform to empower data-driven smartphone research. JMIR Mental Health, 3(2), Article e16. https://doi.org/10.2196/mental.5165
Lange-Küttner, C., Lockl, K., & Gnambs, T. (2025). ADHD and secondary school grades: Evidence from two longitudinal studies. Current Psychology, 44, 16701–16717. https://doi.org/10.1007/s12144-025-08324-7
Hechtman, L., Swanson, J. M., Sibley, M. H., Stehli, A., Owens, E. B., Mitchell, J. T., Arnold, L. E., Molina, B. S., Hinshaw, S. P., Jensen, P. S., Abikoff, H. B., Perez Algorta, G., Howard, A. L., Hoza, B., Etcovitch, J., Houssais, S., Lakes, K. D., Nichols, J. Q., & MTA Cooperative Group. (2016). Functional adult outcomes 16 years after childhood diagnosis of attention-deficit/hyperactivity disorder: MTA results. Journal of the American Academy of Child and Adolescent Psychiatry, 55(11), 945–952.e2. https://doi.org/10.1016/j.jaac.2016.07.774
Emilsson, M., Gustafsson, P. A., Öhnström, G., & Marteinsdottir, I. (2017). Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder. European Child & Adolescent Psychiatry, 26(5), 559–571. https://doi.org/10.1007/s00787-016-0919-1
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Oliwia Marciniak, Grzegorz Jałoszyński, Maciej Makarewicz, Natalia Bylak, Sebastian Konecki, Maria Kurt, Norbert Gromadzki, Anna Gwizdek, Marcin Patryk Barbachowski, Dawid Szczepański, Bruno Makowski
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
